Search Results

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract with Aetna™ Medicare Advantage plans.

Monteris Medical, the leader in minimally invasive image-guided laser interstitial thermal therapy (LITT), announced today that health insurance provider Aetna has updated its medical policy and will provide coverage to its beneficiaries with recurrent brain metastases, radiation necrosis and recurrent glioblastoma.

Neuronetics, Inc. announced a healthcare policy update from Aetna increases access for patients to the Company’s NeuroStar® Advanced Therapy.

After a year of sustained advocacy from the ophthalmology community, Aetna announced this week that it will no longer require pre-approval for cataract surgeries starting July 1, 2022, except for people enrolled in Medicare Advantage in Florida and Georgia.

Aetna®, a CVS Health® company (NYSE CVS), announced the launch of its designated Gene-based, Cellular, and Other Innovative Therapies™ (GCIT) network.

Sutter Health | Aetna announces its plans to offer fully insured products to employers across Northern California for the 2022 enrollment season.

Sutter Health, a not-for-profit healthcare system, and Aetna, a CVS Health Company, announced Jeb Dunkelberger as the new Chief Executive Officer of the Sutter Health | Aetna joint venture, which offers both self-insured PPO and EPO commercial health plan products, as well as Aetna offered fully-insured products to employers in Northern California.

Aetna Better Health of Nevada1, the Medicaid managed care business of Aetna®, a CVS Health® company, announced it has donated $65,000 to R.E.A.C.H., a non-profit organization that works to improve community health services and access to care in Nevada.

Aetna®, a CVS Health® company, announced it will ship boxes of specially curated, over-the-counter items to all its Medicare Advantage members across the country.